{"id":35859,"date":"2025-06-05T16:51:59","date_gmt":"2025-06-05T13:51:59","guid":{"rendered":"https:\/\/massivebio.com\/?p=35859"},"modified":"2025-06-05T22:58:34","modified_gmt":"2025-06-05T19:58:34","slug":"massive-bio-on-cb-insights-ai-drug-research-development-market-map","status":"publish","type":"post","link":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/","title":{"rendered":"Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research &#038; Development Market Map"},"content":{"rendered":"<p class=\"ai-optimize-9 ai-optimize-introduction\"><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p class=\"ai-optimize-introduction ai-optimize-10\">\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p><strong>Chicago, IL, June 5, 2025<\/strong> \u2013 Massive Bio, a leader in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights\u2019 latest AI Drug Research &amp; Development Market Map. This recognition underscores Massive Bio\u2019s innovative contributions to revolutionizing cancer care through advanced artificial intelligence solutions.<\/p>\n<p class=\"ai-optimize-10\">CB Insights\u2019 market map highlights companies at the forefront of leveraging AI to accelerate drug discovery and development. Massive Bio\u2019s inclusion in both the \u201cClinical Trial Matching\u201d and \u201cPatient Recruitment\u201d categories reflects its dual impact on streamlining clinical trial processes and enhancing patient access to cutting-edge therapies.<\/p>\n<p class=\"ai-optimize-11\">\u201cBeing recognized by CB Insights in two critical categories is a testament to our team\u2019s dedication to transforming oncology care,\u201d said <a href=\"https:\/\/www.linkedin.com\/in\/selinkurnaz\/\" target=\"_blank\" rel=\"noopener\"><strong>Selin Kurnaz, PhD<\/strong><\/a>, CEO and Co-Founder of Massive Bio. \u201cOur AI-driven platform is designed to bridge the gap between patients and clinical trials, ensuring that individuals receive the most appropriate and timely treatments available.\u201d<\/p>\n<p class=\"ai-optimize-12\"><a href=\"https:\/\/www.linkedin.com\/in\/arturoloaizabonilla\/\" target=\"_blank\" rel=\"noopener\"><strong>Arturo Loaiza-Bonilla, MD<\/strong><\/a>, Co-Founder and Chief Medical Officer, added, \u201cThis acknowledgment validates our commitment to integrating advanced AI technologies into clinical workflows. By optimizing trial matching and patient recruitment, we\u2019re not only improving operational efficiencies but also enhancing patient outcomes in oncology.\u201d<\/p>\n<p class=\"ai-optimize-13\">This recognition from CB Insights follows a milestone presence at <strong>ASCO25<\/strong>, where <a href=\"https:\/\/www.linkedin.com\/in\/arturoloaizabonilla\/\" target=\"_blank\" rel=\"noopener\"><strong>Arturo Loaiza-Bonilla<\/strong><\/a> presented a <strong>poster session on AI-powered clinical trial matching<\/strong> and participated in the <strong>ASCO\/ESMO Joint Session<\/strong>, emphasizing international collaboration in oncology innovation. In addition, <a href=\"https:\/\/www.linkedin.com\/in\/selinkurnaz\/\" target=\"_blank\" rel=\"noopener\"><strong>Selin Kurnaz<\/strong><\/a> was named a <strong>PCC Wayfinder<\/strong>, honoring her leadership in advancing equitable access and data-driven transformation in cancer care.<\/p>\n<p class=\"ai-optimize-14\">Massive Bio\u2019s platform utilizes sophisticated algorithms and real-time data analytics to match cancer patients with suitable clinical trials, considering factors such as genetic profiles, treatment histories, and geographic locations. This approach has significantly increased trial enrollment rates and reduced the time required to identify eligible participants.<\/p>\n<p class=\"ai-optimize-15\">The company\u2019s dual recognition by CB Insights highlights its comprehensive approach to addressing challenges in clinical trial enrollment and patient engagement. As the demand for personalized cancer treatments grows, Massive Bio continues to lead in providing scalable, AI-driven solutions that connect patients with life-saving clinical trials.<\/p>\n<h3 class=\"ai-optimize-16\"><strong>About Massive Bio <\/strong><\/h3>\n<p class=\"ai-optimize-17\">Massive Bio, co-founded by <a href=\"https:\/\/www.linkedin.com\/in\/selinkurnaz\/\" target=\"_blank\" rel=\"noopener\">Selin Kurnaz<\/a>, <a href=\"https:\/\/www.linkedin.com\/in\/arturoloaizabonilla\/\" target=\"_blank\" rel=\"noopener\">Arturo Loaiza-Bonilla<\/a>, and <a href=\"https:\/\/www.linkedin.com\/in\/cagatayculcuoglu\/\" target=\"_blank\" rel=\"noopener\">\u00c7a\u011fatay \u00c7ulcuo\u011flu<\/a>, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit <a href=\"https:\/\/massivebio.com\/\">www.massivebio.com<\/a>.<\/p>\n<h3 class=\"ai-optimize-39\"><strong>Contacts<\/strong><\/h3>\n<p class=\"ai-optimize-39\"><strong>Massive Bio<br \/>\n<\/strong><strong>Mert Turkkan<br \/>\n<\/strong>Marketing Director<br \/>\n<a href=\"tel:+16464614946\">+1 646 461 4946<\/a><br \/>\n<a href=\"mailto:pr@massivebio.com\">pr@massivebio.com<\/a><\/p>\n<p class=\"ai-optimize-11\">\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Chicago, IL, June 5, 2025 \u2013 Massive Bio, a leader in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights\u2019 latest AI Drug Research &amp; Development Market Map. This recognition underscores Massive Bio\u2019s innovative contributions to revolutionizing cancer care through advanced artificial intelligence solutions. CB Insights\u2019...","protected":false},"author":11,"featured_media":35860,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-35859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research &amp; Development Market Map<\/title>\n<meta name=\"description\" content=\"Massive Bio, a leader in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights\u2019 latest AI Drug Research &amp; Development Market Map.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research &amp; Development Market Map %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio, a leader in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights\u2019 latest AI Drug Research &amp; Development Market Map.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T13:51:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-05T19:58:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/CBI-PR-WEBSITE.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"3584\" \/>\n\t<meta property=\"og:image:height\" content=\"2684\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research & Development Market Map","description":"Massive Bio, a leader in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights\u2019 latest AI Drug Research & Development Market Map.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research & Development Market Map %","og_description":"Massive Bio, a leader in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights\u2019 latest AI Drug Research & Development Market Map.","og_url":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-06-05T13:51:59+00:00","article_modified_time":"2025-06-05T19:58:34+00:00","og_image":[{"width":3584,"height":2684,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/CBI-PR-WEBSITE.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research &#038; Development Market Map","datePublished":"2025-06-05T13:51:59+00:00","dateModified":"2025-06-05T19:58:34+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/"},"wordCount":507,"commentCount":18,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/CBI-PR-WEBSITE.webp","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/","url":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/","name":"Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research & Development Market Map","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/CBI-PR-WEBSITE.webp","datePublished":"2025-06-05T13:51:59+00:00","dateModified":"2025-06-05T19:58:34+00:00","description":"Massive Bio, a leader in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights\u2019 latest AI Drug Research & Development Market Map.","breadcrumb":{"@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/CBI-PR-WEBSITE.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/06\/CBI-PR-WEBSITE.webp","width":3584,"height":2684,"caption":"CBI PR WEBSITE"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/massive-bio-on-cb-insights-ai-drug-research-development-market-map\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Massive Bio Recognized in Two Key Categories on CB Insights\u2019 AI Drug Research &#038; Development Market Map"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=35859"}],"version-history":[{"count":4,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35859\/revisions"}],"predecessor-version":[{"id":35866,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/35859\/revisions\/35866"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/35860"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=35859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=35859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=35859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}